A case of bullous pemphigoid limited to psoriatic plaques

Cutis

Volumn 70, Issue 5, 2002, Pages 283-287

  Kobayashi, Todd T ^a   Elston, Dirk M ^b   Libow, Lester F ^c   David Bajar, Kathleen ^a,c  

^a San Antonio Uniformed Services Health Education Consortium   (United States)

^b Department of Dermatology ^*  (United States)

^c BROOKE ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETRETIN; KERATOLYTIC AGENT;

ARTICLE; BULLOUS PEMPHIGOID; CASE REPORT; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PSORIASIS;

ACITRETIN; HUMANS; KERATOLYTIC AGENTS; MALE; MIDDLE AGED; PEMPHIGOID, BULLOUS; PSORIASIS;

EID: 0142066023     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Person JR, Rogers RS III. Bullous pemphigoid and psoriasis: does subclinical bullous pemphigoid exist? Br J Dermatol. 1976;95:535-540.
2. Abel EA, Bennett A. Bullous pemphigoid: occurrence in psoriasis treated with psoralens plus long-wave ultraviolet radiation. Arch Dematol. 1979;115:988-989.
3. Grunwald MH, David M, Feuerman EJ. Coexistence of psoriasis vulgaris and bullous diseases. J Am Acad Dermatol. 1985;13:224-228.
4. Smith WDF, Jones MSL, Stewart TW, et al. Bullous pemphigoid occurring in psoriatic plaques in association with Hashimoto's thyroiditis. Clin Exp Dermatol. 1991;16:389-391.
5. Kirtschig G, Chow ETY, Venning VA, et al. Acquired subepidermal bullous diseases associated with psoriasis: a clinical, immunopathological and immunogenetic study. Br J Dermatol. 1996;135:738-745.
6. Grattan CE. Evidence of an association between bullous pemphigoid and psoriasis. Br J Dermatol. 1985;113:281-283.
7. Tomasini D, Cerri A, Cozzani E, et al. Development of pemphigus foliaceus in a patient with psoriasis: a simple coincidence? Eur J Dermatol. 1998;8:56-59.
8. Perez GL, Agger WA, Abellera RM, et al. Pemphigus foliaceus coexisting with IgA nephropathy in a patient with psoriasis vulgaris. Int J Dermatol. 1995;34:794-796.
9. Endo Y, Tamura A, Ishikawa O, et al. Psoriasis vulgaris coexistent with epidermolysis bullosa acquisita. Br J Dermatol. 1997;137:783-786.
10. Saeki H, Hayashi N, Komine M, et al. A case of generalized pustular psoriasis followed by bullous disease: an atypical case of bullous pemphigoid or a novel bullous disease? Br J Dermatol. 1996;134:152-155.
11. Smith AG. Epidermolysis bullosa with psoriasis. Lancet. 1934;1:1393.
12. Jaimovich L, de Kaminsky AR, Intebi D, et al. Coexistence of psoriasis and pemphigus erythematosus. Dermatol Int. 1965;4:143-146.
13. Millns JL, Muller SA. The coexistence of psoriasis and lupus erythematosus: an analysis of 27 cases. Arch Dermatol. 1980;116:658-663.
14. Vanderlugt CJ, Miller SD. Epitope spreading. Curr Opin Immunol. 1996;8:831-836.
15. Chan LS, Vanderlugt CJ, Hashimoto T, et al. Epitope spreading: lessons from autoimmune skin disease. J Invest Dermatol. 1998;110:103-109.
16. Chan LS. Epitope spreading in paraneoplastic pemphigus: autoimmune induction in antibody-mediated blistering skin diseases. Arch Dermatol 2000;136:663-664.
17. Liu Z, Diaz LA, Troy JL, et al. A passive transfer model of the organ specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest. 1993;92:2480-2488.
18. Goldberg DJ, Sabolinski M, Bystryn JC. Bullous pemphigoid antibodies: human skin as a substrate for indirect immunofluorescence assay. Arch Dermatol 1985;121:1137-1140.
19. Heng MC, Kloss SG, Kuehn CS, et al. Significance and pathogenesis of basal keratinocyte herniations in psoriasis. J Invest Dermatol. 1986;87:362-366.
20. Vaccaro M, Pergolizzi S, Mondello MR, et al. The dermoepidermal junction in psoriatic skin as revealed by scanning electron microscopy. Arch Dermatol Res. 1999;291:396-399.
21. Perl S, Rappersberger K, Fodinger D, et al. Bullous pemphigoid induced by PUVA therapy. Dermatology. 1996;193:245-247.
22. George PM. Bullous pemphigoid possibly induced by psoralen plus ultraviolet A therapy. Photodermatol Photoimmunol Photomed. 1996;11:185-187.
23. Muramatsu T, Yamashina Y, Shirai T, et al. UVB irradiation reduces the expression of pemphigoid antigens in organ-cultured normal human skin. Arch Dermatol Res. 1994;286:142-144.
24. Albergo RP, Gilgor RS. Delayed onset of bullous pemphigoid after PUVA and sunlight treatment of psoriasis. Cutis. 1982;30:621-624.
25. Robinson JK, Baughman RD, Provost TT. Bullous pemphigoid induced by PUVA therapy: is this the aetiology of the acral bullae produced during PUVA treatment? Br J Dermatol. 1978;99:709-713.
26. Thomsen K, Schmidt H. PUVA-induced bullous pemphigoid. Br J Dermatol. 1976;95:568-569.
27. Glinski W, Jarzabek-Chorzelska M, Kuligowski M, et al. Basement membrane zone as a target for human neutrophil elastase in psoriasis. Arch Dermatol Res. 1990;282:506-511.
28. Basset-Seguin N, Porneuf M, Dereure O, et al. C3d,g deposits in inflammatory skin diseases: use of psoriatic skin as a model of cutaneous inflammation. J Invest Dermatol. 1993;101:827-831.
29. Baird J, Lazarus GS, Belin D, et al. mRNA for tissue-type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis. J Invest Dermatol. 1990;95:548-552.
30. Koerber WA Jr, Price NM, Watson W. Coexistent psoriasis and bullous pemphigoid: a report of six cases. Arch Dermatol. 1978;114:1643-1646.
31. Hisler BM, Aronson PJ, Rudner EJ. Bullous pemphigoid in psoriatic lesions. J Am Acad Dermatol. 1989;20:683-684.
32. Boixeda JP, Medina S, Ledo A. Bullous pemphigoid and psoriasis: treatment with cyclosporine. J Am Acad Dermatol. 1991;24:152.
33. Bianchi L, Gatti S, Nini G. Bullous pemphigoid and severe erythrodermic psoriasis: combined low-dose treatment with cyclosporine and systemic steroids. J Am Acad Dermatol. 1992;27:278.
34. Chen KR, Shimizu S, Miyakawa S, et al. Coexistence of psoriasis and an unusual IgG-mediated subepidermal bullous dermatosis: identification of a novel 200-kDa lower lamina lucida target antigen. Br J Dermatol. 1996;134:340-346.
35. Nousari HC, Sragovich A, Kimyai-Asadi A, et al. Mycophenolate mofetil in autoimmune and inflammatory skin disorders. J Am Acad Dermatol. 1999;40:265-268.
36. Ahmed AR, Winkler NW. Psoriasis and bullous pemphigoid [letter]. Arch Dermatol. 1977;113:845.
37. Primka EJ III, Camisa C. Psoriasis and bullous pemphigoid treated with azathioprine. J Am Acad Dermatol. 1998;39:121-123.